🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Pennsylvania › York

Etid klinik pou Kansè (tout kalite) nan York, PA

8 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote York (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Prospective Study to Assess a Diagnostic Aid for Cancer

Ap rekriteEtid obsèvasyon
  • Cancer Care Associates of York, York
Laj 45 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07046260

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Ap rekriteEtid obsèvasyon
  • Cancer Care Associates of York, York
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06163534

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • WellSpan Health-York Cancer Center, York
  • WellSpan Health-York Hospital, York
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Ap rekriteEtid obsèvasyon
  • Cancer Care Association of York, York
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05257551

WellSpan-THRIVE Cancer QOL Study

Ap rekriteEtid obsèvasyon
  • WellSpan York Cancer Center, York
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT07433660

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Ap rekriteEtid obsèvasyon
  • Cancer Care Associates of York, York
Laj 18 a 99 · Tout sèks · Mizajou Feb 24, 2026 · NCT06207032

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • Cancer Care Associates of York, York
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Ap rekriteEtid obsèvasyon
  • Cancer Care Associates of York, York
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan York

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.